Stay updated with breaking news from Patrick Dolezal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Avadel Pharmaceuticals (AVDL – Research Report...
Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
In a report released yesterday, Patrick Dolezal from LifeSci Capital reiterated a Buy rating on Avadel Pharmaceuticals (AVDL – Research Re...
CymaBay Therapeutics, Inc. (NASDAQ:NASDAQ:CBAY) Q3 2022 Earnings Conference Call November 14, 2022 16:30 ET Company Participants Paul Quinlan - General Counsel Sujal Shah - Chief Executive...
OYST earnings call for the period ending June 30, 2022.